Core Insights - The company reported a significant increase in revenue and profitability for the first half of 2025, with total revenue reaching 15.231 billion yuan and a net profit of 748 million yuan, indicating strong financial performance [1] Financial Performance - The company achieved a gross profit margin of 36.35%, up 13.76 percentage points from 22.59% in the same period last year, reflecting improved operational efficiency [1] - Gross profit amounted to 5.536 billion yuan, an increase of 1.903 billion yuan, representing a growth of 52.40% year-on-year [1] - The net profit attributable to shareholders was 1.09 billion yuan, an increase of 4.72 billion yuan compared to the previous year [1] Cash Flow and Financing - The net cash flow from operating activities was 2.687 billion yuan, a year-on-year increase of 38.15% [1] - The average cost of new borrowings during the reporting period was 2.85%, while the overall financing cost was 3.64%, down 42 basis points from the end of the previous year [1] Credit Rating - The company maintained its AAA credit rating from both China Chengxin International Credit Rating Co., Ltd. and China Securities Pengen Credit Rating Co., Ltd. during the reporting period [1]

22日，两市主要股市强势拉升，沪指涨超1%突破3800点大关，续创10年新高；科创50指数暴涨超8%， 创逾3年半新高。 华西证券指出，A股市场正处于一轮由制度改革、资金结构优化和经济动能转换共同驱动的中长期"慢 牛"新起点；供给侧治理乱象、遏制恶性竞争，叠加需求侧政策持续加码，正在有效扭转市场对长期通 缩和企业盈利塌陷的悲观预期；投资者回报机制的完善，是"慢牛"得以持续的制度基石；居民"存款搬 家"大幕初启，潜在增量资金充沛，正反馈机制正在形成；险资、社保、养老金及潜在平准基金持续入 市，这类资金的长期属性将优化A股投资者结构；"慢牛"的航向将与国家战略高度同频，聚焦新动能、 新技术，辅之以部分大金融、新消费。 （文章来源：证券时报网） 截至收盘，沪指涨1.45%报3825.76点，深证成指涨2.07%报12166.06点，创业板指涨3.36%报2682.55点， 科创50指数涨8.59%报1247.86点，沪深北三市合计成交25793亿元。 盘面上看，农业、银行、食品饮料、石油等板块走低，半导体板块爆发，券商、保险等板块拉升，芯 片、算力、AI产业链股活跃。 ...

金融界8月1日消息，有投资者在互动平台向英科医疗提问：近年来现金和负债都同时增加 ，数额又那 么大，为什么？ 公司回答表示：尊敬的投资者您好，现金增加主要源于经营积累及战略储备，用于海外产能建设、原材 料采购及应对行业周期波动；负债增加则主要为短期借款，用于优化资金结构、支持海外项目及日常运 营，两者配置旨在平衡流动性与战略发展需求，符合公司经营规划。感谢您的关注！ 来源：金融界 ...